Comparison of daily versus continuous administration of somatotropin on growth rate, feed intake, and body composition in intact female rats.
The response to continuous delivery or daily bolus injection of porcine somatotropin (pST) was compared in mature, pituitary-intact female rats (225 g). Growth rate in control rats was approximately 1 g/d over the 14-d study. There was a dose-dependent (0, .4, 1.2, and 3.6 mg of pST/d; P < .001) increase in rate of gain with an interaction (P < .001) of dose and mode of delivery. The slope of the dose-response curve for growth rate was linear on a logarithmic scale for both modes of delivery but was greater for continuous delivery. At the low dose (.4 mg/d) pST stimulated gain (21.7 g/14 d above control, P < .05) when administered by daily injection but failed to stimulate gain (6.0 g/14 d above control, NS) when delivered continuously. At the high dose (3.6 mg/d), gain (above that in control rats) was 49.1 and 79.7 g/14 d for daily and continuous delivery; the two modes were different (P < .05) from each other. Feed intake and liver weights were also stimulated by pST in a dose-dependent manner. The increase in liver size was accompanied by a dose-dependent increase in liver DNA, indicative of an increase in cell number. Increased carcass gain was largely accounted for by increased carcass protein accretion. Rates of carcass lipid accretion were lower than those for protein accretion and were further decreased by pST, particularly by the high dose administered by continuous delivery, where a negative lipid accretion value was observed. Circulating IGF-I was increased by pST (P < .001) but was not affected by the mode of delivery. The results demonstrate that the increased gain observed in mature rats is largely due to lean tissue accretion and is accompanied by an increase in feed intake.
Azain
M J
MJ
Animal and Dairy Science Department, University of Georgia, Athens 30602, USA.
Roberts
T J
TJ
Martin
R J
RJ
Kasser
T R
TR
D000818:Animals; D001823:Body Composition / Q000187:drug effects* / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D004343:Drug Implants; D004435:Eating / Q000187:drug effects* / Q000502:physiology; D005260:Female; D013006:Growth Hormone / Q000008:administration & dosage / Q000494:pharmacology*; D007267:Injections / Q000662:veterinary; D050356:Lipid Metabolism; D008099:Liver / Q000737:chemistry / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley / Q000254:growth & development*; D013045:Species Specificity; D015430:Weight Gain / Q000187:drug effects / Q000502:physiology
D004343:Drug Implants; D013006:Growth Hormone